RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244

ResMed Inc.

ResMed Inc.

RMD

0.00

RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE: RMD) with a Sector Perform and raises the price target from $234 to $244.